the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea
Reps will promote that the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea is superior to oral vancomycin.
That's because Dificid works at least as well as vanco to control C. diff...but seems to have a lower risk of recurrence.
There's one less recurrence within one month for every 10 patients treated with Dificid instead of oral vancomycin.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote